Oral Concurrent 9 – Placental Disease and Associated Hypertension Published: 2026 14:15 – 14:30 47 | Determinants of Spontaneous and Iatrogenic Preterm Birth in a Nationwide Cohort M. D. Huiskamp1; A. C. J. Ravelli2; R. J. Burger2; J. W. Nijkamp3; B. W. J. W. Mol4 1Monash University, Utrecht University, Amsterdam UMC, Melbourne, Australia; 2Amsterdam UMC, Amsterdam, Netherlands; 3UMC Utrecht, Utrecht, Netherlands; 4Monash University, Melbourne, Australia Objective: To evaluate the independent and combined effects of parity, fetal sex, socioeconomic status (SES), and season of conception on spontaneous and iatrogenic preterm birth (PTB). Study Design: Population‐based cohort study using data from the Netherlands Perinatal Registry (PERINED, 2010–2019). Singleton pregnancies between 24 + 0 and 42 + 6 weeks’ gestation were included. Pregnancies with congenital anomalies, antenatal death, or missing data on parity, fetal sex, SES, or month of conception were excluded. Outcomes were spontaneous PTB (sPTB) and iatrogenic PTB (iPTB) <37 weeks. Multivariable logistic regression was adjusted for maternal age, ethnicity, and year of delivery. Predicted risks were calculated to assess combined effects. Results: Among 1,565,214 singleton pregnancies, 3.6% had sPTB and 1.5% iPTB. Nulliparity was the strongest determinant of both sPTB (aOR 1.83, 95% CI 1.79–1.86) and iPTB (aOR 1.59, 95% CI 1.55–1.64). Male fetal sex was associated with sPTB (aOR 1.28, 95% CI 1.26–1.30), but not with iPTB. Low SES was associated with both sPTB (aOR 1.08, 95% CI 1.06–1.11) and iPTB (aOR 1.11, 95% CI 1.07–1.15). Spring conception was associated with sPTB (aOR 1.08, 95% CI 1.05–1.10), but not with iPTB. A significant parity–SES interaction was observed for both subtypes (p < 0.001). Predicted risks for sPTB ranged from 2.0% (95% CI 2.0–2.1) in multiparous women with a female fetus, highSES, and autumn conception to 5.6% (95% CI 5.4–5.7) in nulliparous women with a male fetus, mid‐SES, and springconception. Predicted iPTB risks were lower, ranging from 1.0% (95% CI 0.95–1.05) to 2.3% (95% CI 2.0–2.6) across comparable profiles (Figures 1–2). Conclusion: Parity is the primary determinant of preterm birth. Fetal sex, SES, and season differ between sPTB and iPTB. Different combinations of these factors are associated with a nearly threefold difference in absolute sPTB risk. 14:30 – 14:45 48 | Factors Affecting Postpartum Hospital Readmission Rates in Patients With Peripartum Hypertension Shagun Tuli1; Panagiotis Cherouveim1; Melissa N. Castillo2; Jenny LaChance1; Jay Holmes1; Ivana Vettraino1 1Hurley Medical Center, Flint, MI; 2Michigan State University College of Human Medicine, East Lansing, MI Objective: To identify clinical and sociodemographic factors associated with postpartum hospital readmission among patients with peripartum hypertension at a tertiary safety net hospital that serves a high‐risk population. Study Design: A retrospective cohort study was conducted between 2016 and 2024. The primary outcome was hospital readmission for hypertensive disorder within 30 days of delivery. Charts were abstracted for patient demographics, mode of delivery, and discharge antihypertensive therapy. Baseline characteristics were compared between patients that were readmitted vs those who were not. Readmission rates were also compared by specific antihypertensive medication prescribed at discharge. Statistical analysis used parametric and non‐parametric tests as indicated. Multivariate logistic regression analysis was utilized for hospital readmission including patient's age, race, delivery mode, and discharge with or without antihypertensive medications. Results: 5766 patients met criteria for inclusion. The 30‐day readmission rate was 6.1%. Readmitted patients were more likely to be older (30.1 vs 28.7 years, p < 0.001) and to have undergone cesarean delivery (need comparison numbers p < 015). Black patients had significantly higher readmission rates when compared to White patients (50.1% vs 44.7%, p = 0.017). In adjusted analyses, discharge without antihypertensive medication was independently associated with a 2.6 times higher odds of readmission (aOR = 2.58, 95% CI: 1.79–3.70, p < .001). Specifically, when compared to patients discharged without antihypertensive medications, patients discharged on labetalol had lower readmission rates (3.4% vs 6.5%, p < 0.001) as did patients discharged on nifedipine (2.2% vs 6.5%, p < 0.001). Conclusion: These findings suggest that postpartum readmission among patients with peripartum hypertension is driven by systems‐level factors that warrant targeted intervention. In a high‐risk population, standardized discharge protocols, and initiation of antihypertensive medication management may serve to reduce preventable readmissions. 14:45 – 15:00 49 | Metabolic Reprogramming Drives Endothelial Dysfunction via Cytoskeletal Reorganization in sFGR Placentas Xiya Sun; Nana Huang; Youzhen Zhang; Jingyu Liu; Jing Yang; Yangyu Zhao Peking University Third Hospital, Beijing, China (People's Republic). Objective: Selective fetal growth restriction (sFGR) is associated with profound placental vascular abnormalities, yet the underlying molecular mechanisms remain poorly understood. Here, we investigated whether metabolic reprogramming of vascular endothelial cells drives cytoskeletal disruption, ultimately impairing angiogenesis in sFGR. Study Design: A clinical cohort of sFGR (sFGR‐L, n = 6; sFGR‐S, n = 6) and healthy monochorionic diamniotic (MCDA, n = 6) controls was enrolled. Placental tissue, umbilical cord blood, and primary HUVECs were collected. Multi‐omics profiling (RNA‐seq and targeted metabolomics) with experimental validation identified differential metabolic and transcriptomic signatures; functional assays characterized the metabolic‐cytoskeletal regulatory network. Results: Histopathological examination of sFGR‐S placentas showed markedly reduced vascular density, indicating angiogenic failure. Transcriptomic analysis revealed dysregulation of PI3K‐Akt signaling, focal adhesion, and cytoskeleton regulation (p < 0.05). Targeted metabolomics identified an energy deficit, evidenced by downregulation of glycolysis/gluconeogenesis and pyruvate metabolism intermediates (p < 0.05). sFGR‐S HUVECs exhibited reduced proliferation and migration, disorganized cytoskeletal architecture, and mitochondrial dysfunction. Tube formation assays revealed severity‐dependent impairment, with sFGR‐S HUVECs showing up to a 16.4% reduction in branching length and a 26.6% decrease in network junctions versus MCDA controls. Integrated multi‐omics analysis revealed a co‐regulatory network in which metabolic dysregulation drives endothelial dysfunction by altering cytoskeleton‐related gene expression. Conclusion: These findings indicate that disruption of the metabolic–cytoskeletal regulatory network is a central driver of impaired angiogenesis in sFGR. Metabolic insufficiency compromises cytoskeletal integrity, impairing vascular formation. These results clarify the mechanistic basis of sFGR and suggest endothelial metabolism and cytoskeletal dynamics as potential therapeutic targets. 15:00 – 15:15 50 | Characterising New Symptoms That Occur Before an Eclamptic Seizure; A Multi‐National Prospective Study Roxanne Hastie1; Farhatulain Ahmed2; Parinaz Mehdipour1; Bernard Yan1; Susan P. Walker3; Jacqui Visser4; Anam Bashir2; Lyle Gurrin1; Anthea Lindquist1; Jessica A. Atkinson1; Catherine Cluver5; Lina Bergman6; Stephen Tong3 1University of Melbourne, Melbourne, Australia; 2Fatima Memorial Hospital, Lahore, Pakistan; 3University of Melbourne Department of Obstetrics, Gynaecology and Newborn Health, Melbourne, Australia; 4Stellenbosch University, Stellenbosch, South Africa; 5Department of Obstetrics and Gynaecology, Faculty of Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa; 6University of Gothenburg, Gothenburg, Sweden Objective: Magnesium sulphate halves the risk of eclampsia. However, prediction of eclampsia is poor meaning it is difficult to target who to give it to. Headache and visual changes are commonly relied on in the clinic but in fact, have poor predictive value. We set out to find new symptoms that may be associated with imminent eclampsia. Study Design: This multi‐national prospective study recruited women with eclampsia or preeclampsia across South Africa and Pakistan. We approached women within 7 days of an eclamptic seizure with a list of symptoms and asked whether they experienced them before seizure onset. We also asked women diagnosed with preeclampsia but did not develop eclampsia (comparison group). Symptoms included those already thought to be associated with eclampsia and symptoms of other neurological conditions not yet investigated among women with eclampsia. Results: We recruited 1355 women with preeclampsia and 341 women with eclampsia. Headache (88% vs 74.1%; odds ratio [OR] 2.56 (95% CI 1.81–3.62)) and visual disturbance (65% vs %24.6; OR 5.73 (95% CI 4.44–7.39)) were only moderately associated with eclampsia. We identified ten symptoms with odds ratios over 10 for eclampsia. Odds ratios were 42.03 (95% CI 23.66,74.68; 30.5% eclampsia vs 1% preeclampsia) for twitching/jerking limbs, 36.00 (95% CI 18.34,70.65; 21.1% vs 0.7%) for affected hearing, 33.60 (95% CI 21.39,52.78; 38.7% vs 1.8%) for affected mind state, 33.12 (95% CI 19.46, 54.37) for impaired speech, 23.71 (95% CI 16.49,34.10) for feelings of doom, 26.59 (95% CI 7.82,90.41) for severe vertigo, 20.52 (95% CI 14.22,29.63) for confusion, 18.16 (95% CI 10.76,30.66) for jitters, 15.18 (95% CI 11.34,20.33) for difficulty concentrating and 10.49 (95% CI 6.76, 16.27) for weakness/paralysis. Conclusion: In this large, multi‐national study we have identified novel symptoms that occur imminently before eclampsia. Their links with eclampsia are far stronger than commonly used indicators, such as headache and visual disturbances. 15:15 – 15:30 51 | Keep an Eye on Preeclampsia: The Role of Maternal Ocular Point‐of‐Care Ultrasound Beatrice Valentini1; Elvira Di Pasquo1; Alice Dal Miglio1; Alessandro Petrecca2; Federico Quintiliani3; Tullio Ghi4 1IRCCS Fondazione Policlinico Universitario A. Gemelli, Rome, Italy; 2Università Cattolica del Sacro Cuore, Rome, Italy; 3Catholic University of the Sacred Heart, Rome, Italy; 4Department of Woman and Child Health Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy Objective: To determine whether maternal ocular Point‐of‐Care Ultrasound (POCUS) can provide bedside identification of women with preeclampsia (PE) at higher risk of maternal compromise or adverse perinatal outcome. Study Design: In this ambispective cohort study, women with new‐onset PE and a viable singleton pregnancy between 22 + 0 and 36 + 6 weeks’ gestation underwent maternal ocular POCUS at hospital admission, performed by a single experienced operator. Optic nerve sheath diameter (ONSD) was measured 3 mm posterior to the globe, and ophthalmic artery Doppler velocimetry was used to derive the second‐to‐first peak systolic velocity (PSV) ratio. At follow‐up the occurrence of maternal compromise defined by ISSHP criteria, and/or of fetal growth restriction (FGR) according to Delphi consensus criteria was noted. Ocular POCUS parameters were compared across groups, and their predictive performance was evaluated using logistic regression and ROC curve analysis. Results: Among 45 women included, 21 (46.7%) developed signs of maternal compromise and 28 (62.2%) were complicated by FGR. Those who developed signs of maternal compromise showed a significantly increased ONSD at admission compared to women without signs of maternal compromise (7.65 ± 1.0 vs 6.85 ± 1.3 mm; p = 0.03). Logistic regression analysis showed that ONSD was associated with the presence of signs of maternal compromise, with an AUC of 0.7 (p = 0.04). A threshold value of 7.45 mm provided the best discrimination, yielding a positive predictive value (PPV) of 63.6% and a negative predictive value (NPV) of 69.6%. Furthermore, in PE associated with FGR a reduced PSV ratio at the level of ophthalmic artery was found compared with non‐FGR cases ((0.69 ± 0.1 vs 0.77 ± 0.1; p = 0.04). Conclusion: Maternal ocular POCUS seems valuable in predicting the occurrence of complications in women with preeclampsia, with ONSD and ophthalmic artery identifying women at higher risk of maternal compromise and fetal growth restriction respectively.